FDA Inspection 1121294 — Hetero Drugs Limited

Hetero Drugs Limited — FEI 3003510514

The FDA completed an inspection of Hetero Drugs Limited on February 14, 2020 in Gummadidala Mandal, Sangareddy. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gummadidala Mandal, Sangareddy (India)